CDSCO UID IMP/IVD/2022/000535_27ec1d9ff3104d387a0fdeed218197b6_1b19054abef3807775aeb29c9405c0e8

STA Compact Max 3

Imperial Biotek·Device Class Class A·India CDSCO
Registration details
UID
IMP/IVD/2022/000535_27ec1d9ff3104d387a0fdeed218197b6_1b19054abef3807775aeb29c9405c0e8
Device class
Class A
License holder
Imperial Biotek
Approving authority
CDSCO
Product information
to perform clotting, chromogenic and immunoassay tests on human venous plasmas the results of which aid in the diagnosis of coagulation abnormalities or in monitoring anticoagulant therapy
Similar products (1)
Other products with the same name or brand
STA Compact Max 3
LABX
Class A
Other products from Imperial Biotek
Products from the same license holder (10 products)
STA Compact Max 3 with cap piercing and coag expert
Class A
STA R Max 3 CP 230/50 Coag Expert
Class A
STA Satellite Max
Class A
STA® - FM Calibrator
Brand: STAGO
Class C
STA® - ImmunoDef IX
Brand: STAGO
Class C
STA® - CaCl2 0.025 M
Brand: STAGO
Class A
STA® - FDP Control
Brand: STAGO
Class C
STA® - Control LA 1+2
Brand: STAGO
Class C
STA-ImmunoDef II-STA-ImmunoDef II is an Immuno depleted Human Plasma intended for the use in tests for the determination of Factor II Activity in Plasma with STA-R & STA Compact, These tests require the inclusion of Factor
Class C
STA® - Hepanorm® HBPM/LMWH
Brand: STAGO
Class C
About this record

STA Compact Max 3 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000535_27ec1d9ff3104d387a0fdeed218197b6_1b19054abef3807775aeb29c9405c0e8. The license holder is Imperial Biotek, and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.